Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Neurology, Headache, ASSISTANT PROFESSOR | Medicine, General Internal Medicine
Fingerprint
Dive into the research topics where Fred Cohen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Artificial Intelligence and Predictive Modeling in the Management and Treatment of Episodic Migraine
Natekar, A. & Cohen, F., Dec 2025, In: Current Pain and Headache Reports. 29, 1, 56.Research output: Contribution to journal › Article › peer-review
-
Artificial intelligence terminology, methodology, and critical appraisal: A primer for headache clinicians and researchers
Dumkrieger, G. M., Chiang, C. C., Zhang, P., Minen, M. T., Cohen, F. & Hranilovich, J. A., Jan 2025, In: Headache. 65, 1, p. 180-190 11 p.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings
Cohen, F., Brooks, C. V., Sun, D., Buse, D. C., Reed, M. L., Fanning, K. M. & Lipton, R. B., Jan 2025, In: Headache. 65, 1, p. 11-13 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Counting the cost: How migraine shapes lives and economies
Shirane, R. & Cohen, F., Jun 2025, In: Headache. 65, 6, p. 905-906 2 p.Research output: Contribution to journal › Editorial
-
Temporal Artery Ultrasonography for the Diagnosis of Giant Cell Arteritis
Thal, K. A., Starling, A. & Cohen, F., Mar 2025, In: American Family Physician. 111, 3, p. 258-259 2 p.Research output: Contribution to journal › Article › peer-review
Press/Media
-
Weekly: Intellia Therapeutics (NTLA: $8.12) sinks 8% on robust volume; -72c [8.1%] Vol Index 1.5 [1 is avg]
10/05/25
1 item of Media coverage
Press/Media
-
Weekly: Intellia Therapeutics (NTLA: $8.84) gains 6%; +53c [6.4%]
3/05/25
1 item of Media coverage
Press/Media
-
Weekly: Intellia Therapeutics (NTLA: $8.31) surges 15% on firm volume; +$1.08 [14.9%]
26/04/25
1 item of Media coverage
Press/Media
-
Weekly: Intellia Therapeutics (NTLA: $7.23) gains 7% on average volume; +46c [6.8%]
21/04/25
1 item of Media coverage
Press/Media
-
Weekly: Intellia Therapeutics (NTLA: $7.41) surges 12% on robust volume; +78c [11.8%] Vol Index 1.5 [1 is avg]
12/04/25
1 item of Media coverage
Press/Media